检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

445PD ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK- rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with crizotinib

Lanjun Zhang,Yuankai Shi,D.S.W. Tan,Bei Hu,L. Xiaoqing,Ying Cheng,Jiaojiao Zhou,T. An,Y. Lu,Bo Zhu,C. Bai,A. Jappe,Vanessa Q. Passos,Yvonne Y. Lau, Q. Wang,Y-L. Wu

Annals of Oncology（2016）

引用 1|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要